503BMarketingA compound.BUZZ program
For 503B facilities and everyone who sells to compounding pharmacies

Is your 503B ready to own the 503A market?

Nine questions, about two minutes. We tell you straight whether a pharmacy-owner acquisition build makes sense for your company, and what it would cost.

Question 1 of 9about two minutes

For 503B outsourcing facilities, ingredient suppliers, equipment and software vendors, and other licensed healthcare businesses.

Our own account, reaching your buyer

We already reach compounding pharmacy owners. Every day.

compound.BUZZ sells to 503A owners for a living. These are the numbers from doing it, pulled from Meta on August 28, 2026, not typed in.

90,415pharmacy owners and pharmacists reached since May
450raised hands: 347 lead forms and 103 booked calls
$32.48per owner lead on our best campaign (264 leads)
3.06%click-through rate, lifetime, across 319,981 impressions
0100200$50$10066May152Jun57Jul72Aug$28.50$44.17$67.89$88.18
  • Owner leads per month (lead forms)
  • Cost per lead

compound.BUZZ’s own Meta account reaching compounding pharmacy owners and pharmacists, May 12 to August 28, 2026. 347 lead-form leads and 103 booked calls on $18,813 of spend. Pulled from Meta through Pipeboard, not typed in. The cost climbs in July because the reachable audience is about 7,500 pharmacies and roughly 25,000 profiles, so the same people were being shown the ads more than five times a month. That is the constraint we plan around for you, and it is why creative volume and a second channel matter more than a bigger daily budget.

What $363 a day buys

The honest range, from our own numbers.

Most agencies show you a chart they drew. Here's what $10,890 a month would have produced in our account, reaching owners with our offer, at our best month, our blended cost, and our worst month.

382owner leads a month if our best month's cost held ($28.50, set at about $60 a day)
201at our lifetime cost per lead ($54.22)
123at our worst month ($88.18)
14-21days from signed to live, depending on the level

Those are our results reaching compounding pharmacy owners with our offer. The top of the range assumes the cost holds as spend rises; on a 25,000-person audience it didn't, which is why the plan splits spend across channels instead of buying frequency. Your offer, your lines, and your states will produce their own number. That number is what the call works out, with your real market on the screen. Individual results vary.

The market, by the numbers

Your buyer already buys this way.

7,500compounding pharmacies in the US
96FDA-registered 503B outsourcing facilities, TX 17, FL 15, NJ 9
75%of 503Bs already distribute sterile preparations to traditional pharmacies
33%of pharmacies dispensed a 503B-sourced weight-management compound in the last two years

What compounders compound, by volume

The median compounding pharmacy fills 350 compounded prescriptions a week for 150 prescribers, works 100 formulations, and employs 15 people. 61% take no insurance for compounds, so they buy on margin and trust, not on formulary.

Hormone replacement36%
Veterinary14%
Weight management11%
Dermatology8%
Men's health7%

Sources: FDA, Registered Outsourcing Facilities (updated 8/28/2026) · Alliance for Pharmacy Compounding, Snapshot of Pharmacy Compounding in America 2025-2026.

Built for three kinds of company

Same buyer. Three different reasons to be known.

Meta can't target “sells to compounders.” The ads name you in the first line so the right owner stops and the wrong one scrolls.

01 · 503B outsourcing facilities

The line has to stay full.

A cGMP plant is a fixed cost that never sleeps. Every week of open capacity is margin you never get back, and adding reps to fill it's slow and expensive.

What we do: put your facility in front of the 503A owners in the states you ship to, with education on sourcing, shortages, and office-use, so they call you before the rep ever calls them.

02 · API and ingredient suppliers

Pharmacies pick a supplier and stay.

Switching is rare and it happens on trust and formulation support, not price. The supplier who taught the pharmacist something is the one who gets the next order.

What we do: make your company the teacher. Education-first ads and content, under your brand, to every owner and pharmacist in charge in your footprint, all year, not just at the conference.

03 · Equipment, software, services

The inspection is the buying trigger.

81 percent of compounders invested in facility upgrades for compliance. The pharmacist in charge buys the hood, the monitoring, and the software from whoever explained what changed.

What we do: lead with the explanation. Compliance-led education that puts your name next to the answer, then a follow-up system that books the demo.

What we actually install

The same machine, pointed at your buyer.

  1. 01

    Get in front of the owners you can sell to

    Education-first Meta and Instagram ads, state by state, specialty by specialty. No drug names, no pricing, nothing that gets an account shut down. LinkedIn for the titles Meta can't see.

  2. 02

    Turn interest into a name and a number

    A separate education domain and landing pages built for pharmacy owners, with tracking wired in so you see every raised hand and which ad produced it.

  3. 03

    Make sure nobody waits

    Your own CRM sub-account, instant follow-up, and an AI setter behind your team that picks up anything they miss and books it while they sleep.

  4. 04

    Keep your name in front of them

    Ongoing education, social, and video under your brand, so when the owner is ready to add a line or switch a supplier, you're the one they think of first.

Built in 14 to 21 days. You assemble none of it. Pricing is matched to your market on the call.

For the team that answers the phone

PharmacyCloser AI

Leads are the easy part. The hard part is a rep who knows how a compounding pharmacy owner thinks, buys, and objects. PharmacyCloser AI is the sales school we run our own pharmacy reps through, rebuilt for the people who sell to pharmacies.

$8,997one time, your whole sales team

  • Forty narrated modules on how a 503A owner runs the business, makes money, and chooses a 503B, a supplier, or a vendor
  • Call architecture for the first conversation with an owner, the pharmacist in charge, and the buyer, including the questions that surface the real objection
  • Objection flows in the owner’s own words: price, switching, quality, compliance, “we already have a supplier”
  • AI role-play partner that plays the owner, scores the rep against a rubric, and doesn't pass anyone who can't isolate the objection
  • Follow-up cadences and templates for the 14 days after a raised hand, wired into the CRM we install
  • A coach view so your sales leader sees every rep’s scores, drills, and tapes

Included in the top engagement level. Available on its own for teams that already have lead flow and want it to close. Sally walks through the curriculum on the call.

See if your team qualifies
In their words

What owners say when the machine is pointed at them.

These are compounding pharmacy owners talking about the education-first ads running under their own names. The same owners are your buyers, and this is how they respond to the mechanism.

We have leads pouring in, it is awesome. We had 10 fill out the form last night so I am working on those right now.
Compounding pharmacy owner, Kentucky
We hear from all of our doctors that they are seeing us everywhere.
Compounding pharmacy owner
The lead we just got was number 23 for the week.
Compounding pharmacy owner, Kentucky

Real clients, their words unchanged, names withheld. Individual results vary.

Fair questions.

Will this get our ad account shut down?

No, because we don't advertise drugs. We build education with you and advertise that, in the business-to-business lane the platforms allow. No drug names, no pricing, no patient claims. It's the reason our pharmacy clients stay running while other people get banned, and it's the same lane we run for you.

Who exactly are you putting our name in front of?

Compounding pharmacy owners, pharmacists in charge, and the people who decide which 503B, which supplier, and which vendor a pharmacy buys from. About 7,500 compounding pharmacies in the country, roughly 25,000 reachable profiles on Meta with the targeting we already run, plus LinkedIn for the titles Meta can't see.

We already have a sales team. Why would we need this?

Then you already know the cost of a rep cold-calling pharmacies that don't pick up. We don't replace the team, we fill its calendar with owners who raised a hand and already know your name. A rep working warm, educated leads closes differently from a rep opening cold.

What does it cost?

Sally quotes it live on the call, matched to your market and your lines. Ad spend is separate, goes straight to Meta from your own account, and we take none of it. The one fixed price on this page is PharmacyCloser AI, because it's a product, not an engagement.

We sell in twenty states. Can you handle that?

Yes. The ads only run where you're licensed to sell, state by state, and the education is written for the specialties you actually serve. A nationwide supplier and a two-state 503B get different maps and the same machine.

Does LegitScript matter here?

It opens a second, more product-forward advertising lane on top of the education lane. It isn't required to start. Roughly a quarter of compounders hold it, and we tell you on the call whether it's worth your time.

How fast does anything happen?

Fourteen to twenty-one days to build, depending on the level. On our fastest compound.BUZZ pharmacy launch the first lead came in 84 minutes after the campaign went live. Yours will be its own number, and we show you the real ones on the call.

Nine questions and you'll know.

Start